Journal of the Korean Academy of Child and Adolescent Psychiatry

Korean Academy of Child and Adolescent Psychiatry (대한소아청소년정신의학회)
권호 표지
DOI QR코드

DOI QR Code

Preliminary Investigation of Association between Methylphenidate and Serum Growth Markers in Children with Attention-Deficit/Hyperactivity Disorder: A Cross-Sectional Case-Control Study

  • Kim, Woo Jin (Department of Psychiatry, Dong-A University Graduate School of Medicine) ;
  • Bang, Young Rong (Department of Psychiatry, Dong-A University Hospital) ;
  • Kang, Je-Wook (Department of Psychiatry, Inje University Busan Paik Hospital) ;
  • Yoo, Jae Ho (Department of Pediatrics, Dong-A University Hospital) ;
  • Kim, Seong Hwan (Department of Psychiatry, Dong-A University Hospital) ;
  • Park, Jae Hong (Department of Psychiatry, Dong-A University Hospital)
  • Received : 2020.03.19
  • Accepted : 2020.06.15
  • Published : 2020.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: It remains unclear whether methylphenidate (MPH) has yadverse effects on growth in children. This study aimed to investigate the association of MPH with serum biological markers of growth in children with attention-deficit/hyperactivity disorder (ADHD). Methods: The present study included 103 children with ADHD (64 drug-naive children, 39 MPH-treated children) and 112 control subjects. Children with ADHD were diagnosed on the basis of a semi-structured interview. Levels of biochemical markers of growth, including insulin-like growth factor-I, thyroid stimulating hormone (TSH), free T4, calcium, phosphorus, alkaline phosphatase, vitamin D, hemoglobin, total protein, albumin, total cholesterol, and hematocrit were measured in these individuals. Results: Except in case of TSH, no intergroup differences were found in the levels of the growth markers. The levels of TSH were found to be lower in the MPH-treated boys with ADHD than in the drug-naive and control groups (p<0.05), although the levels of TSH in all the groups were within normal limits. Conclusion: In this cross-sectional study, no significant association was found between MPH and growth markers. This calls for the need to carry out prospective longitudinal research studies in the future that investigate the effect of MPH on the growth trajectory in children.

Keywords

References

  1. Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2002;41(2 Suppl):26S-49S. https://doi.org/10.1097/00004583-200202001-00003
  2. Lisska MC, Rivkees SA. Daily methylphenidate use slows the growth of children: a community based study. J Pediatr Endocrinol Metab 2003;16:711-718. https://doi.org/10.1515/jpem.2003.16.5.711
  3. Swanson J, Greenhill L, Wigal T, Kollins S, Stehli A, Davies M, et al. Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry 2006;45:1304-1313. https://doi.org/10.1097/01.chi.0000235075.25038.5a
  4. Kang KD, Yun SW, Chung U, Kim TH, Park JH, Park IH, et al. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder. Hum Psychopharmacol 2016;31:76-82. https://doi.org/10.1002/hup.2514
  5. Spencer TJ, Faraone SV, Biederman J, Lerner M, Cooper KM, Zimmerman B; CONCERTA STUDY GROUP. Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD? J Am Acad Child Adolesc Psychiatry 2006;45:527-537. https://doi.org/10.1097/01.chi.0000205710.01690.d4
  6. Ptacek R, Kuzelova H, Stefano GB, Raboch J, Kream RM, Goetz M. ADHD and growth: questions still unanswered. Neuro Endocrinol Lett 2014;35:1-6.
  7. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M; Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008;122:398-417. https://doi.org/10.1542/peds.2007-1894
  8. Allen LH. Nutritional influences on linear growth: a general review. Eur J Clin Nutr 1994;48 Suppl 1:S75-S89.
  9. Park JH, Seo JH, Hong YS, Kim YM, Kang JW, Yoo JH, et al. Blood lead concentrations and attention deficit hyperactivity disorder in Korean children: a hospital-based case control study. BMC Pediatr 2016;16:156. https://doi.org/10.1186/s12887-016-0696-5
  10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. text revision (DSM-IV-TR). Washington, DC: American Psychiatric Press;2000.
  11. Kim YS, Cheon KA, Kim BN, Chang SA, Yoo HJ, Kim JW, et al. The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (K-SADS-PL-K). Yonsei Med J 2004;45:81-89. https://doi.org/10.3349/ymj.2004.45.1.81
  12. Kim JH, Yun S, Hwang SS, Shim JO, Chae HW, Lee YJ, et al. The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects. Korean J Pediatr 2018;61:135-149. https://doi.org/10.3345/kjp.2018.61.5.135
  13. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000;85:3990-3993. https://doi.org/10.1210/jcem.85.11.6984
  14. Harvey CB, O'Shea PJ, Scott AJ, Robson H, Siebler T, Shalet SM, et al. Molecular mechanisms of thyroid hormone effects on bone growth and function. Mol Genet Metab 2002;75:17-30. https://doi.org/10.1006/mgme.2001.3268
  15. Shao YY, Wang L, Ballock RT. Thyroid hormone and the growth plate. Rev Endocr Metab Disord 2006;7:265-271. https://doi.org/10.1007/s11154-006-9012-2
  16. Glorieux FH, Travers R, Taylor A, Bowen JR, Rauch F, Norman M, et al. Normative data for iliac bone histomorphometry in growing children. Bone 2000;26:103-109. https://doi.org/10.1016/S8756-3282(99)00257-4
  17. Clarke B. Normal bone anatomy and physiology. Clin J Am Soc Nephrol 2008;3 Suppl 3:S131-S139. https://doi.org/10.2215/CJN.04151206
  18. Toren P, Silbergeld A, Eldar S, Laor N, Wolmer L, Koren S, et al. Lack of effect of methylphenidate on serum growth hormone (GH), GH-binding protein, and insulin-like growth factor I. Clin Neuropharmacol 1997;20:264-269. https://doi.org/10.1097/00002826-199706000-00011
  19. Bereket A, Turan S, Karaman MG, Haklar G, Ozbay F, Yazgan MY. Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment. Horm Res 2005;63:159-164. https://doi.org/10.1159/000084683
  20. Goksugur SB, Tufan AE, Semiz M, Gunes C, Bekdas M, Tosun M, et al. Vitamin D status in children with attention-deficit-hyperactivity disorder. Pediatr Int 2014;56:515-519. https://doi.org/10.1111/ped.12286
  21. Holick MF, Chen TC, Lu Z, Sauter E. Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res 2007;22 Suppl 2:V28-V33. https://doi.org/10.1359/jbmr.07s211
  22. Chung IH, Kim HJ, Chung S, Yoo EG. Vitamin D deficiency in Korean children: prevalence, risk factors, and the relationship with parathyroid hormone levels. Ann Pediatr Endocrinol Metab 2014;19:86-90. https://doi.org/10.6065/apem.2014.19.2.86
  23. Haugen BR. Drugs that suppress TSH or cause central hypothyroidism. Best Pract Res Clin Endocrinol Metab 2009;23:793-800. https://doi.org/10.1016/j.beem.2009.08.003
  24. Zader SJ, Williams E, Buryk MA. Mental health conditions and hyperthyroidism. Pediatrics 2019;144:e20182874. https://doi.org/10.1542/peds.2018-2874
  25. Soliman A, De Sanctis V, Elalaily R, Bedair S. Advances in pubertal growth and factors influencing it: can we increase pubertal growth? Indian J Endocrinol Metab 2014;18(Suppl 1):S53-S62.